4.1
薬物分布: 概要
体内の薬物分布は、薬物がさまざまな区画を 2 方向に移動する動的なプロセスです。血流から組織へ (組織吸収)、組織から血流へ (組織放出または再分布) という 2 つの方向への移動です。このプロセスは受動的であり、主に 2 つの変数によって駆動されます。血流と血管外組織間の濃度勾配および、薬物が細胞…
分布とは、体内の異なるコンパートメント間で薬物が双方向に動くことを指します。
これは、血液と血管外組織との間の濃度勾配によって駆動される受動的なプロセスです。
最初に、血液中の遊離薬物は急速に毛細血管壁に浸透し、細胞外液またはECFに入ります。
そこから、組織細胞膜を横切って細胞内液に到達します。
この手順はレート制限手順であり、2 つの主要な要因に依存します。1つ目は、細胞外組織への灌流速度で、これにより薬物が組織にどれだけ早く送達されるかが決まります。
2つ目は、薬物の膜透過性です。これは、薬物が細胞膜をどれだけ簡単に通過できるかを決定します。
薬物の分布に影響を与える他の要因は、臓器や組織のサイズ、生理学的障壁、および個人です。
薬物が分布する体液の理論体積は、分布体積によって示されます。
View the full transcript and gain access to JoVE Core videos
Q1: What is drug distribution and how does it work in the body?
Drug distribution is the two-way movement of a drug between different body compartments, driven by concentration gradients. Free drug in the blood passively permeates capillary walls and enters the extracellular fluid. From there, it crosses cell membranes to reach intracellular fluid. This process is passive and relies on the concentration difference between blood and tissues to move drugs throughout the body.
Q2: Why is crossing the cell membrane the rate-limiting step in drug distribution?
Crossing the cell membrane is the rate-limiting step because it determines how quickly a drug reaches its site of action inside cells. Two factors control this step: perfusion rate, which determines how fast the drug reaches tissue, and membrane permeability, which dictates how easily the drug crosses the cell membrane. Together, these factors govern the overall speed of drug distribution throughout the body.
Q3: How does plasma protein binding affect drug distribution?
Drugs bound to plasma proteins like albumin become inactive and cannot cross cell membranes, limiting their availability for tissue uptake. Only free, unbound drug can distribute into tissues. This binding significantly restricts how much active drug reaches target cells, making protein binding a critical factor in determining drug distribution patterns and therapeutic effectiveness.
Q4: What role do physiological barriers play in drug distribution?
Physiological barriers like the blood-brain barrier restrict passage of certain substances, protecting sensitive organs such as the brain. These barriers limit which drugs can reach specific tissues, affecting overall distribution patterns. Individual differences in barrier function and drug characteristics determine whether a drug can cross these protective boundaries to reach its target tissue.
Q5: How does tissue release occur after drug distribution?
Tissue release occurs when drug concentrations in the bloodstream decrease due to metabolism or elimination, creating a reverse concentration gradient. Drugs diffuse back from tissues into the blood, driven by this concentration difference. The tissue's affinity for the drug, presence of binding proteins, and the drug's ability to diffuse through membranes all influence the rate of tissue release.
Q6: What factors besides perfusion and permeability influence drug distribution?
Organ or tissue size impacts how much drug can be accommodated, while individual differences such as genetic variations, metabolism rates, and overall health influence distribution patterns. These factors work alongside perfusion rate and membrane permeability to determine the final distribution of a drug throughout the body and its therapeutic effectiveness.
Q7: What does volume of distribution represent in pharmacokinetics?
Volume of distribution is a hypothetical volume representing the body fluid space where a drug disperses to achieve the observed blood concentration. It quantifies the extent of drug distribution within the body and helps predict how widely a drug spreads. A larger volume of distribution indicates the drug distributes extensively into tissues, while a smaller volume suggests limited tissue penetration.